Emanuel Schwarz

Dr. Emanuel Schwarz


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Schizophrenia Research
Verified
Journal Article
Closed access
ESEmanuel Schwarz
Emanuel Schwarz
JMJohanna Maukonen
Johanna Maukonen
THTiina Hyytiäinen
Tiina Hyytiäinen
TKTuula Kieseppä
Tuula Kieseppä
Matej OresicMatej Oresic
Matej Oresic
Jaana SuvisaariJaana Suvisaari
Jaana Suvisaari

9 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
UBUrs Braun
Urs Braun
AHAnais Harneit
Anais Harneit
GPGiulio Pergola
Giulio Pergola
TMTommaso Menara
Tommaso Menara
ASAxel Schäfer
Axel Schäfer
HTHeike Tost
Heike Tost
Dynamical brain state transitions are critical for flexible working memory but the network mechanisms are incompletely understood. Here, we show that working memory performance entails brain-wide switching between activity states using a combination of functional magnetic resonance imaging in healthy controls and individuals with schizophrenia, pharmacological fMRI, genetic analyses and network control theory. The stability of states relates to dopamine D1 receptor gene expression while state transitions are influenced by D2 receptor expression and pharmacological modulation. Individuals with schizophrenia show altered network control properties, including a more diverse energy landscape and decreased stability of working memory representations. Our results demonstrate the relevance of dopamine signaling for the steering of whole-brain network dynamics during working memory and link these processes to schizophrenia pathophysiology.

10 August 2022 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
AOAet O’leary
Aet O’leary
NFNoelia Fernandez-Castillo
Noelia Fernandez-Castillo
GGGabriela Gan
Gabriela Gan
YYYunbo Yang
Yunbo Yang
AYAnna Y. Yotova
Anna Y. Yotova
ARAndreas Reif
Andreas Reif
Common variation in the gene encoding the neuron-specific RNA splicing factor RNA Binding Fox-1 Homolog 1 (RBFOX1) has been identified as a risk factor for several psychiatric conditions, and rare genetic variants have been found causal for autism spectrum disorder (ASD). Here, we explored the genetic landscape of RBFOX1 more deeply, integrating evidence from existing and new human studies as well as studies in Rbfox1 knockout mice. Mining existing data from large-scale studies of human common genetic variants, we confirmed gene-based and genome-wide association of RBFOX1 with risk tolerance, major depressive disorder and schizophrenia. Data on six mental disorders revealed copy number losses and gains to be more frequent in ASD cases than in controls. Consistently, RBFOX1 expression appeared decreased in post-mortem frontal and temporal cortices of individuals with ASD and prefrontal cortex of individuals with schizophrenia. Brain-functional MRI studies demonstrated that carriers of a common RBFOX1 variant, rs6500744, displayed increased neural reactivity to emotional stimuli, reduced prefrontal processing during cognitive control, and enhanced fear expression after fear conditioning, going along with increased avoidance behaviour. Investigating Rbfox1 neuron-specific knockout mice allowed us to further specify the role of this gene in behaviour. The model was characterised by pronounced hyperactivity, stereotyped behaviour, impairments in fear acquisition and extinction, reduced social interest, and lack of aggression; it provides excellent construct and face validity as an animal model of ASD. In conclusion, convergent translational evidence shows that common variants in RBFOX1 are associated with a broad spectrum of psychiatric traits and disorders, while rare genetic variation seems to expose to early-onset neurodevelopmental psychiatric disorders with and without developmental delay like ASD, in particular. Studying the pleiotropic nature of RBFOX1 can profoundly enhance our understanding of mental disorder vulnerability.

28 March 2022 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
JRJaroslav Rokicki
Jaroslav Rokicki
TKTobias Kaufmann
Tobias Kaufmann
ALAnn-Marie G. de Lange
Ann-Marie G. de Lange
DMDennis van der Meer
Dennis van der Meer
SBShahram Bahrami
Shahram Bahrami
DQDaniel S. Quintana
Daniel S. Quintana

1 June 2020 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
JCJunfang Chen
Junfang Chen
ZZZhenxiang Zang
Zhenxiang Zang
UBUrs Braun
Urs Braun
KSKristina Schwarz
Kristina Schwarz
AHAnais Harneit
Anais Harneit
ESEmanuel Schwarz
Emanuel Schwarz
Schizophrenia is a severe brain disorder thought to be caused by a complex interplay of genetic predisposition and environmental exposure.1-5 In the context of gene-environment interplay and developmental programming,6,7 epigenetic mechanisms, such as DNA methylation, have received substantial attention in schizophrenia8,9 and other neuropsychiatric disorders.10-13 As epigenetic mechanisms may account for heritability not captured by other current methods, such as polygenic risk scores (PRSs), potential interactions between genetic susceptibility and epigenetic changes are of particular interest. To our knowledge, to date, much of this work has studied single genes. For example, methylation at the single-nucleotide polymorphism rs6265 within the neurodevelopmentally important brain-derived neurotrophic factor gene shows a genotype-dependent association with working memory (WM), hypoxia-associated early life events, and a WM-associated schizophrenia intermediate phenotype.14 Similarly, methylation differences in dopamine receptor D4 predict WM, suggesting that the dopaminergic methylation status could affect cognitive functions in a dissociable manner.15 Likewise, membrane-bound catechol-O-methyltransferase promoter methylation is associated with dorsolateral prefrontal cortex (DLPFC) activity during WM16 and methylation of the COMT Val(158) allele with lifetime stress, WM performance, and prefrontal activity during WM.17

12 June 2024 in Psychiatry Research
Verified
Journal Article
Closed access
SVSebastian Volkmer
Sebastian Volkmer
AMAndreas Meyer-Lindenberg
Andreas Meyer-Lindenberg
ESEmanuel Schwarz
Emanuel Schwarz